Clinical and experimental assessment of the effects of a new topical treatment with praziquantel in the management of rosacea

International Journal of Dermatology

Volumn 54, Issue 4, 2015, Pages 481-487

  Bribeche, Mohamed Ridha ^a   Fedotov, Valery P ^a   Gladichev, Vitaly V ^a   Pukhalskaya, Daria M ^a   Kolitcheva, Natalia L ^a  

^a ZAPORIZHZHIA STATE MEDICAL UNIVERSITY   (Ukraine)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PRAZIQUANTEL; OINTMENT;

ADULT; AGAR DIFFUSION; AGED; ANTIMICROBIAL ACTIVITY; ARTICLE; BACILLUS; CANDIDA ALBICANS; CLINICAL ASSESSMENT; CLINICAL ERYTHEMA ASSESSMENT SCALE; CONTROLLED STUDY; DERMATOLOGY LIFE QUALITY INDEX; DRUG EFFICACY; DRUG SAFETY; DRY SKIN; ESCHERICHIA COLI; FEMALE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INVESTIGATOR GLOBAL ASSESSMENT SCALE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NONHUMAN; OINTMENT; PILOT STUDY; PSEUDOMONAS AERUGINOSA; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; ROSACEA; SINGLE BLIND PROCEDURE; STAPHYLOCOCCUS AUREUS; MIDDLE AGED; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; OINTMENTS; PILOT PROJECTS; PRAZIQUANTEL; ROSACEA; SINGLE-BLIND METHOD;

EID: 84925258564     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/ijd.12552     Document Type: Article

References (17)

1. Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol 2002; 46: 584-587.
2. Berg M, Liden S. An epidemiological study of rosacea. Acta Derm Venereol 1989; 69: 419-423.
3. Lomholt G. Prevalence of skin diseases in a population - a census study from the Faroe Islands. Dan Med Bull 1964; 11: 1-7.
4. Salamon M, Chodkiewicz J, Sysa-Jedrzejowska A, et al. Quality of life in patients with rosacea. Przegl Lek 2008; 65: 385-389.
5. Svanstrom H, Pasternak B, Hviid A. Use of azythromicine and death from cardiovascular causes. N Engl J Med 2013; 368: 1704-1712.
6. Berman B, Perez OA, Zell D. Update on rosacea and anti-inflammatory dose doxycycline. Drugs Today (Barc) 2007; 43: 27-34.
7. Utzinger J, Keiser J. Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control. Expert Opin Pharmacother 2004; 5: 263-285.
8. Doenhoff MJ, Cioli D, Utzinger J. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr Opin Infect Dis 2008; 21: 659-667.
9. Devi A, Singh V, Bhatt AB. In vitro antibacterial activity of pomegranate and Daru (wild pomegranate) against dental plaque bacteria. Int J Pharm Pharm Sci 2011; 3: 182-184.
10. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for clinical routine use. Clin Exp Dermatol 1994; 19: 210-216.
11. Fallon PG, Doenhoff MJ. Active immunization of mice with Schistosoma mansoni worm membrane antigens enhances efficacy of praziquantel. Parasite Immunol 1995; 17: 261-268.
12. Ismail M, Botros S, Metwally A, et al. Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. Am J Trop Med Hyg 1999; 60: 932-935.
13. Appleby LJ, Nausch N, Bourke CD, et al. Chitinase 3-like 1 protein levels are elevated in Schistosoma haematobium infected children. PLoS Negl Trop Dis 2012; 6: e1898.
14. Rathcke CN, Johansen JS, Vestergaard H. YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance. Inflamm Res 2006; 55: 53-59.
15. Imay I, Tsuda T, Aochi S, et al. YKL-40 (chitinase 3-like-1) as a biomarker for psoriasis vulgaris and pustular psoriasis. J Dermatol Sci 2011; 64: 75-77.
16. Lacey N, Delaney S, Kavanagh K, et al. Mite-related bacterial antigens stimulate inflammatory cells in rosacea. Br J Dermatol 2007; 157: 474-481.
17. O'Reilly N, Menezes N, Kavanagh K. Positive correlation between serum immunoreactivity to Demodex-associated Bacillus proteins and erythematotelangiectatic rosacea. Br J Dermatol 2012; 167: 1032-1036.